These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 22932396)
21. Autophagy and proteasome interconnect to coordinate cross-presentation through MHC class I pathway in B cells. Dasari V; Rehan S; Tey SK; Smyth MJ; Smith C; Khanna R Immunol Cell Biol; 2016 Nov; 94(10):964-974. PubMed ID: 27297581 [TBL] [Abstract][Full Text] [Related]
22. MHC class I antigen presentation: learning from viral evasion strategies. Hansen TH; Bouvier M Nat Rev Immunol; 2009 Jul; 9(7):503-13. PubMed ID: 19498380 [TBL] [Abstract][Full Text] [Related]
23. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma. Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627 [TBL] [Abstract][Full Text] [Related]
24. Viral interference with MHC class I antigen presentation pathway: the battle continues. Ambagala AP; Solheim JC; Srikumaran S Vet Immunol Immunopathol; 2005 Aug; 107(1-2):1-15. PubMed ID: 15978672 [TBL] [Abstract][Full Text] [Related]
25. MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy. Possamaï D; Hanafi LA; Bellemare-Pelletier A; Hamelin K; Thébault P; Hébert MJ; Gagnon É; Leclerc D; Lapointe R PLoS One; 2021; 16(12):e0261987. PubMed ID: 34972158 [TBL] [Abstract][Full Text] [Related]
26. Influenza A virus infection-induced macroautophagy facilitates MHC class II-restricted endogenous presentation of an immunodominant viral epitope. Deng J; Lu C; Liu C; Oveissi S; Fairlie WD; Lee EF; Bilsel P; Puthalakath H; Chen W FEBS J; 2021 May; 288(10):3164-3185. PubMed ID: 33830641 [TBL] [Abstract][Full Text] [Related]
27. New insights into the structure of the MHC class I peptide-loading complex and mechanisms of TAP inhibition by viral immune evasion proteins. Praest P; Liaci AM; Förster F; Wiertz EJHJ Mol Immunol; 2019 Sep; 113():103-114. PubMed ID: 29606337 [TBL] [Abstract][Full Text] [Related]
28. The MHC class I antigen presentation pathway: strategies for viral immune evasion. Hewitt EW Immunology; 2003 Oct; 110(2):163-9. PubMed ID: 14511229 [TBL] [Abstract][Full Text] [Related]
29. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation. Apcher S; Daskalogianni C; Manoury B; Fåhraeus R PLoS Pathog; 2010 Oct; 6(10):e1001151. PubMed ID: 20976201 [TBL] [Abstract][Full Text] [Related]
30. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
31. Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I-dependent presentation. Zarei S; Leuba F; Arrighi JF; Hauser C; Piguet V J Allergy Clin Immunol; 2002 Jun; 109(6):988-94. PubMed ID: 12063529 [TBL] [Abstract][Full Text] [Related]
32. The impact of macroautophagy on CD8(+) T-cell-mediated antiviral immunity. Perot BP; Ingersoll MA; Albert ML Immunol Rev; 2013 Sep; 255(1):40-56. PubMed ID: 23947346 [TBL] [Abstract][Full Text] [Related]
33. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells. Svensson M; Pfeifer J; Stockinger B; Wick MJ Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741 [TBL] [Abstract][Full Text] [Related]
34. Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes. Reimann J; Böhm W; Schirmbeck R Biol Chem Hoppe Seyler; 1994 Nov; 375(11):731-6. PubMed ID: 7535058 [TBL] [Abstract][Full Text] [Related]
35. A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen. Merzougui N; Kratzer R; Saveanu L; van Endert P EMBO Rep; 2011 Dec; 12(12):1257-64. PubMed ID: 22037009 [TBL] [Abstract][Full Text] [Related]
36. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Braciale TJ; Morrison LA; Sweetser MT; Sambrook J; Gething MJ; Braciale VL Immunol Rev; 1987 Aug; 98():95-114. PubMed ID: 2443444 [TBL] [Abstract][Full Text] [Related]
37. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Yamamoto K; Venida A; Yano J; Biancur DE; Kakiuchi M; Gupta S; Sohn ASW; Mukhopadhyay S; Lin EY; Parker SJ; Banh RS; Paulo JA; Wen KW; Debnath J; Kim GE; Mancias JD; Fearon DT; Perera RM; Kimmelman AC Nature; 2020 May; 581(7806):100-105. PubMed ID: 32376951 [TBL] [Abstract][Full Text] [Related]
38. MHC class I alleles and their exploration of the antigen-processing machinery. Groothuis TA; Griekspoor AC; Neijssen JJ; Herberts CA; Neefjes JJ Immunol Rev; 2005 Oct; 207():60-76. PubMed ID: 16181327 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333 [TBL] [Abstract][Full Text] [Related]
40. The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways. Zuo J; Quinn LL; Tamblyn J; Thomas WA; Feederle R; Delecluse HJ; Hislop AD; Rowe M J Virol; 2011 Feb; 85(4):1604-14. PubMed ID: 21123379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]